179 related articles for article (PubMed ID: 35274173)
1. Safety and Oncologic Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma Recurrences in the Ipsilateral Kidney Following Partial Nephrectomy.
Rossi J; Cazzato RL; de Marini P; Auloge P; Autrusseau PA; Dalili D; Tricard T; Poussot B; Garnon J; Lang H; Gangi A
Cardiovasc Intervent Radiol; 2022 May; 45(5):656-664. PubMed ID: 35274173
[TBL] [Abstract][Full Text] [Related]
2. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
3. Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation.
Okhunov Z; Chamberlin J; Moreira DM; George A; Babaian K; Shah P; Youssef R; Kaler KS; Lobko II; Kavoussi L; Landman J
J Endourol; 2016 Jun; 30(6):632-7. PubMed ID: 27009377
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results.
Beemster PW; Barwari K; Mamoulakis C; Wijkstra H; de la Rosette JJ; Laguna MP
BJU Int; 2011 Aug; 108(4):577-82. PubMed ID: 21044249
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous Cryoablation of Renal Cell Carcinoma with Sinus Vein Involvement Based on Preprocedural Imaging.
Atwell TD; Kurup AN; Boorjian SA; Schmitz JJ; Thompson RH; Leibovich BC; Schmit GD
J Vasc Interv Radiol; 2017 Dec; 28(12):1651-1657. PubMed ID: 29042169
[TBL] [Abstract][Full Text] [Related]
6. Safety and oncologic efficacy of percutaneous MRI-guided cryoablation of intraparenchymal renal cancers.
De Marini P; Cazzato RL; Garnon J; Dalili D; Leonard-Lorant I; Leclerc L; Autrusseau PA; Auloge P; Weiss J; Tricard T; Lang H; Gangi A
Diagn Interv Imaging; 2021 Sep; 102(9):531-538. PubMed ID: 33931365
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
8. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous cryoablation for clinical T3a renal cell carcinoma (< 7 cm) with segmental vein involvement or perinephric fat invasion based on preoperative evaluation of high-resolution multidetector computed tomography scan.
Uka M; Iguchi T; Okawa N; Matsui Y; Tomita K; Umakoshi N; Munetomo K; Gobara H; Araki M; Hiraki T
Jpn J Radiol; 2022 Nov; 40(11):1201-1209. PubMed ID: 35727459
[TBL] [Abstract][Full Text] [Related]
10. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
[TBL] [Abstract][Full Text] [Related]
11. Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience.
Tanagho YS; Bhayani SB; Kim EH; Figenshau RS
J Endourol; 2013 Dec; 27(12):1477-86. PubMed ID: 24283518
[TBL] [Abstract][Full Text] [Related]
12. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous renal cryoablation after partial nephrectomy: technical feasibility, complications and outcomes.
Hegg RM; Schmit GD; Boorjian SA; McDonald RJ; Kurup AN; Weisbrod AJ; Callstrom MR; Atwell TD; Thompson RH
J Urol; 2013 Apr; 189(4):1243-8. PubMed ID: 23123377
[TBL] [Abstract][Full Text] [Related]
14. Cryoablation of renal fossa recurrence after radical nephrectomy.
Suson KD; Richard H; Phelan MW
J Endourol; 2011 Apr; 25(4):559-62. PubMed ID: 21381955
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous CT- and MRI-guided Cryoablation of cT1 Renal Cell Carcinoma: Intermediate- to Long-term Outcomes in 307 Patients.
Bhagavatula SK; Tuncali K; Shyn PB; Levesque VM; Chang SL; Silverman SG
Radiology; 2020 Sep; 296(3):687-695. PubMed ID: 32633677
[TBL] [Abstract][Full Text] [Related]
16. Outcomes After Cryoablation Versus Partial Nephrectomy for Sporadic Renal Tumors in a Solitary Kidney: A Propensity Score Analysis.
Bhindi B; Mason RJ; Haddad MM; Boorjian SA; Leibovich BC; Atwell TD; Weisbrod AJ; Schmit GD; Thompson RH
Eur Urol; 2018 Feb; 73(2):254-259. PubMed ID: 28967553
[TBL] [Abstract][Full Text] [Related]
17. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
[TBL] [Abstract][Full Text] [Related]
18. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
Andrade HS; Zargar H; Caputo PA; Akca O; Kara O; Ramirez D; Haber GP; Stein RJ; Kaouk JH
Eur Urol; 2016 Jun; 69(6):1149-54. PubMed ID: 26719014
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
[TBL] [Abstract][Full Text] [Related]
20. Safety and Oncologic Outcomes of Magnetic Resonance Imaging-Guided Cryoablation of Renal Cell Carcinoma: A 10-Year Single-Center Experience.
Cazzato RL; De Marini P; Leonard-Lorant I; Leclerc L; Auloge P; Tricard T; Dalili D; Garnon J; Lang H; Gangi A
Invest Radiol; 2021 Mar; 56(3):153-162. PubMed ID: 32897930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
